Inspire Investing, LLC Novavax Inc Transaction History

Inspire Investing, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$36.28 - $75.29 $247,937 - $514,531	-6,834 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$69.73 - $142.9 $21,337 - $43,727	-306 Reduced 4.29%	6,834 $503,000
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $960,758 - $1.56 Million	7,140 New	7,140 $1.02 Million
Q4 2021 Feb 03, 2022	SELL	$134.56 - $217.97 $1.05 Million - $1.7 Million	-7,790 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$177.8 - $270.58 $1.39 Million - $2.11 Million	7,790 New	7,790 $1.62 Million
Q2 2021 Aug 10, 2021	SELL	$121.0 - $257.67 $356,708 - $759,611	-2,948 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$112.98 - $319.93 $89,932 - $254,664	-796 Reduced 21.26%	2,948 $535,000
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $294,802 - $522,288	3,744 New	3,744 $417,000

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.